Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections

Author： Plosker Greg L.   Figgitt David P.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.9, 2005-01, pp. : 945-964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linezolid: A Review of its Use in the Management of Serious Gram-Positive Infections

By Perry C.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. : 525-551

Adis International

Access to resources Recommend Favorite

Quinupristin/Dalfopristin: A Review of its Use in the Management of Serious Gram-Positive Infections

By Lamb H.M.   Figgitt D.P.   Faulds D.  

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1061-1097

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

By Falagas Matthew E.   Vardakas Konstantinos Z.  

Drug Safety, Vol. 31, Iss. 9, 2008-01 ,pp. : 753-768

Adis International

Access to resources Recommend Favorite

Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections

By Holliday S.M.   Benfield P.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 359-377

Adis International

Access to resources Recommend Favorite

Linezolid: In Infants and Children with Severe Gram-Positive Infections

By Lyseng-Williamson K.A.   Goa K.L.  

Pediatric Drugs, Vol. 5, Iss. 6, 2003-01 ,pp. : 419-429

Adis International

Access to resources Recommend Favorite